(Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -2,447,050.00%-48.94K | -499.16%-84.07K | 94.98%-669 | -147.73%-28.92K | 97.30%-1.57K | 100.00%2 | -143.03%-14.03K | -103.36%-13.32K | -97.02%60.58K | -24.60%-58.24K |
Net income from continuing operations | -269.98%-42.5K | -925.34%-185.6K | -22.81%-33.18K | 45.02%-132.15K | -78.58%-75.54K | -143.48%-11.49K | 89.34%-18.1K | 50.59%-27.02K | -123.27%-240.38K | -105.41%-42.3K |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,628.68%-480.41K | ---148.87K |
Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 10.22%661.1K | 119.27%87.62K |
Remuneration paid in stock | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -42.02%23.09K | 198.97%17.4K |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -59.19%85.48K | -69.78%11.51K |
Change In working capital | -156.01%-6.44K | 123.81%9.11K | 137.31%32.51K | 782.61%103.23K | 350.74%73.97K | 113.38%11.49K | 103.35%4.07K | -93.24%13.7K | -95.83%11.7K | 109.28%16.41K |
-Change in receivables | -254.87%-1.45K | -70.31%-3.69K | -521.39%-2.24K | 221.19%61.67K | 115.82%63.26K | -83.62%935 | -103.37%-2.17K | -100.13%-360 | -107.00%-50.89K | -347.13%-399.97K |
-Change in payables and accrued expense | -147.26%-4.99K | 105.23%12.8K | 147.14%34.75K | -33.59%41.56K | -97.43%10.71K | 111.53%10.56K | 103.36%6.24K | 118.38%14.06K | 114.01%62.58K | 576.30%416.38K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -2,447,050.00%-48.94K | -499.16%-84.07K | 94.98%-669 | -147.73%-28.92K | 97.30%-1.57K | 100.00%2 | -143.03%-14.03K | -103.36%-13.32K | -97.02%60.58K | -24.60%-58.24K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 16.93%-26.43K | -106.95%-183 | |||||||
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 16.93%-26.43K | -106.95%-183 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 16.93%-26.43K | -106.95%-183 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 8.17K | 0 | 0 | 0 | 49.42%-751.93K | -168.19%-4.55K | ||||
Net issuance payments of debt | --8.17K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 49.42%-751.93K | -168.19%-4.55K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --8.17K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 49.42%-751.93K | -168.19%-4.55K |
Net cash flow | ||||||||||
Beginning cash position | 4,417.11%104.53K | -99.54%75 | -97.49%744 | -96.03%29.66K | -97.50%2.32K | -99.23%2.31K | -95.89%16.35K | -96.03%29.66K | 196.26%747.44K | -88.06%92.63K |
Current changes in cash | -2,038,600.00%-40.77K | 844.43%104.45K | 94.98%-669 | 95.97%-28.92K | 97.50%-1.57K | 100.00%2 | 92.29%-14.03K | 94.93%-13.32K | -240.14%-717.78K | -68.25%-62.97K |
End cash Position | 2,652.85%63.76K | 4,417.11%104.53K | -99.54%75 | -97.49%744 | -97.49%744 | -97.50%2.32K | -99.23%2.31K | -95.89%16.35K | -96.03%29.66K | -96.03%29.66K |
Free cash from | -2,447,050.00%-48.94K | -499.16%-84.07K | 94.98%-669 | -184.67%-28.92K | 97.31%-1.57K | 100.00%2 | -162.28%-14.03K | -103.50%-13.32K | -98.29%34.15K | -32.46%-58.42K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data